Selected article for: "global concern and novel coronavirus outbreak"

Author: Feng, Xiao; Xie, Xiaoyu; Song, Shouyang; Chen, Wenjun; Bian, Hongjun; Rui, Fajuan; Zhu, Qiang; Ren, Wanhua; Qin, Chengyong; Qi, Jianni
Title: Current directions, conceptions and viewpoints on 2019-nCoV (Review)
  • Cord-id: zactn57s
  • Document date: 2020_11_25
  • ID: zactn57s
    Snippet: On December 31, 2019, the first case of a novel coronavirus infection was reported in Wuhan, China. The ongoing outbreak of the 2019 novel coronavirus (2019-nCoV) has caused immense global concern. According to the recommendations of the International Health Regulations Emergency Committee and the facts and cases that 215 other countries have also reported to date, the World Health Organization Director-General announced that the outbreak of 2019-nCoV constitutes a public health emergency of int
    Document: On December 31, 2019, the first case of a novel coronavirus infection was reported in Wuhan, China. The ongoing outbreak of the 2019 novel coronavirus (2019-nCoV) has caused immense global concern. According to the recommendations of the International Health Regulations Emergency Committee and the facts and cases that 215 other countries have also reported to date, the World Health Organization Director-General announced that the outbreak of 2019-nCoV constitutes a public health emergency of international concern and a severe threat to the human health worldwide. To date, the prevalence of the virus has continued in waves and is increasing globally. The present review briefly introduces the epidemiology of 2019-nCoV, as well as viral structural characteristics, and receptors and cells that may act after entering the body, laboratory examinations, imaging and pathological features, clinical manifestations, complications, treatment and management.

    Search related documents:
    Co phrase search for related documents
    • abnormal result and acute ards respiratory distress syndrome: 1
    • abnormal result and acute lung injury: 1
    • abnormal result and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • abnormal result and liver damage: 1
    • abnormal result and lung injury: 1
    • accurate method and acute kidney injury: 1
    • accurate method and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute kidney injury: 1, 2, 3, 4
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • ace inhibitor and lung injury: 1, 2, 3, 4
    • activation aggregation and acute lung injury: 1, 2
    • activation aggregation and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • activation aggregation and lung injury: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and adolescent child: 1
    • acute ards respiratory distress syndrome and liver cell: 1, 2
    • acute ards respiratory distress syndrome and lung alveolar epithelium: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25